{"id":"W3170117047","doi":"10.1200/jco.2021.39.15_suppl.e13020","title":"First-line treatment with a cyclin-dependent kinase 4/6 inhibitor combined with an aromatase inhibitor for hormone receptor-positive, human epidermal growth factor receptor-2 negative metastatic breast cancer: Population-based outcomes for patients treated in Alberta, Canada.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Baker Hughes (Canada); University of Calgary","funders":"","keywords":"Palbociclib; Medicine; Internal medicine; Metastatic breast cancer; Aromatase inhibitor; Oncology; Population; Breast cancer; Progression-free survival; Proportional hazards model; Cancer; Hazard ratio; Gastroenterology; Aromatase; Chemotherapy; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004239327,0.0005266336,0.002758857,0.0001957747,0.0001703685,0.00002117431,0.0001405842,0.0002252914,0.00009281761],"category_scores_gemma":[0.001065252,0.0003428078,0.0003497382,0.0002863586,0.0001625317,0.0003195104,0.00002054532,0.0004582819,6.124598e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002674544,"about_ca_system_score_gemma":0.004430959,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.09815706,"about_ca_topic_score_gemma":0.6661358,"domain_scores_codex":[0.9952252,0.0004977304,0.002584155,0.0005866701,0.00057077,0.0005354786],"domain_scores_gemma":[0.9901471,0.004752364,0.002352434,0.000291424,0.001769599,0.0006870889],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1180329,0.01174274,0.84139,0.0001377183,0.00198719,0.0003491074,0.0002312268,0.0005090244,0.0001943922,0.00002320141,0.0002080967,0.0251944],"study_design_scores_gemma":[0.1100361,0.07056803,0.8137602,0.0004612473,0.00102502,0.00006887331,0.0002090959,0.0002237375,0.002332834,0.00009494981,0.0007710747,0.0004488948],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9837126,0.00008882043,0.0002892121,0.01104434,0.000405754,0.001996631,0.002442881,0.00001518452,0.000004627996],"genre_scores_gemma":[0.9848216,0.0000490344,0.01185348,0.001191311,0.0004751326,0.0003767333,0.001027863,0.00009127906,0.0001136107],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5679788,"threshold_uncertainty_score":0.9999024,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03958041499443192,"score_gpt":0.37131618201223,"score_spread":0.3317357670177981,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}